BacterOMIC is a diagnostic system developed by Scope Fluidics, a biotechnology company. The system aims to expedite and enhance the effectiveness of patient treatment by identifying the most accurately targeted therapies for individual patients. BacterOMIC allows for the identification of the effectiveness of a range of 25 antibiotics used in the treatment of respiratory, blood, urinary, and skin infections. Scope Fluidics is also preparing for commercial production of the BacterOMIC system and extending patent protection in the United States of America.
Headquarters
Ul. Ogrodowa 58
Warsaw; Mazowieckie;
Postal Code: 00-876
Contact Details: Purchase the Bacteromic Sp. z o.o. report to view the information.
Website: http://www.bacteromic.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service